In AT, there is an increased release of pro-inflammatory adipokines, such as monocyte chemotactic protein 1 (MCP-1), accompanied by a simultaneous decrease in the release of anti-inflammatory adipokines, such as adiponectin [58,59]. This evidence concerns the gene CCL2 and ataxia telangiectasia.